PRAEVENTIX

President: Douglas Pippin

University:
Temple University
Startup Officer: Steve Nappi

Technology Area: 
  • Pharmaceuticals and Medical
Praeventix, LLC is an integrated biopharmaceutical company focusing on the discovery, development and marketing of
novel signal transduction modulating agents for the treatment of Inflammatory Bowel Disease disorders in unmet clinical
indications.
Articles to be posted soon.

Please publish modules in offcanvas position.